Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Cleveland Biolabs, Inc. (NQ: CBLI)
1.630 USD  +0.070 (+4.49%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Cleveland Biolabs, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Cleveland BioLabs to Present at BARDA and NIAID Sponsored Symposium on Development of Radiation Medical Countermeasures
January 24, 2013
from GlobeNewswire News Releases
Traders Get Bullish on Shares of Cleveland Biolabs, Shares Up 5.8% (CBLI)
January 07, 2013
from Comtex SmarTrend® News Briefs
Cleveland Biolabs Up 5.2%, Shares Break Through Resistance (CBLI)
January 03, 2013
from Comtex SmarTrend® News Briefs
UPDATE: Oppenheimer Initiates Cleveland BioLabs at Outperform; A Unique Opportunity
December 06, 2012
Oppenheimer initiated coverage on Cleveland BioLabs (NASDAQ: CBLI ) with an Outperform rating and a $3 price target. Oppenheimer commented, "Biodefense drug development has a unique risk/reward risk... Read More
category Benzinga , Initiation , CBLI , and 5 more.
from Latest Articles from Benzinga.com
StreetInsider.com Pre-Open Movers 12/6: (WLT) (ZNGA) (GRMN) Higher; (MW) (AAPL) (DB) Lower (more...)
December 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7928966 for the full story. Read More
from StreetInsider.com News Articles
Oppenheimer Starts Cleveland BioLabs (CBLI) at Outperform
December 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7928907 for the full story. Read More
from StreetInsider.com News Articles
Notable Analyst Rating Changes 12/04: (FRAN) (GFI) (SFD) Upgraded; (IACI) (CLF) (RGC) Downgraded
December 04, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7921686 for the full story. Read More
from StreetInsider.com News Articles
Burrill Starts Cleveland BioLabs (CBLI) at Market Outperform
December 04, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7920383 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs to Present at Oppenheimer 23rd Annual Healthcare Conference
December 04, 2012
from GlobeNewswire News Releases
Cleveland BioLabs (CBLI), Panacela Labs Receive $4.6M Contract in Russia for Xenomycins Development
November 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7903843 for the full story. Read More
from StreetInsider.com News Articles
Panacela Labs, a Subsidiary of Cleveland BioLabs, Signs Contract for Approximately $4.6 Million With Russian Ministry of Industry and Trade for Development of Xenomycins
November 27, 2012
from GlobeNewswire News Releases
Investors look to Lighten Up on Shares of Cleveland Biolabs, Shares Down 8.3% (CBLI)
November 12, 2012
from Comtex SmarTrend® News Briefs
Cleveland BioLabs Reports Third Quarter 2012 Financial Results and Development Progress
November 08, 2012
from GlobeNewswire News Releases
Trading Radar for 11/08: Disney (DIS), Lannett (LCI), Allscripts (MDRX), Wendy's (WEN) Report
November 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7853688 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod(TM) (CBLB502) on Graft-Versus-Tumor Activity in Models of Allogeneic Bone Marrow Transplantation
November 06, 2012
from GlobeNewswire News Releases
Cleveland BioLabs to Report Third Quarter Financial Results and Provide Operational Update on November 8
October 30, 2012
from GlobeNewswire News Releases
Department of Defense Chemical Biological and Medical Systems Continues Funding Under Development Contract With Cleveland BioLabs for Entolimod(TM) (CBLB502)
October 25, 2012
from GlobeNewswire News Releases
Slew Of Disappointing Earnings Sinks Stocks
October 19, 2012
A slew of disappointing corporate earnings sent the markets into a tailspin with the Dow collapsing 205 points to 13,343. Nasdaq plunged 67 points to 3005. Read More
category Market News
from MarketMinute.com Market Updates
Top 4 Stocks of NASDAQ Rising on Unusual Volume (CPNO, SATC, ATHN, CBLI)
October 19, 2012
Los Angelas, CA -- (SBWIRE) -- 10/19/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... Read More
from SBWire - Latest Press Releases
Unusual 11 Mid-Day Movers 10/19: (GURE) (RVBD) (CALL) Higher; (CBLI) (PXLW) (MIG) Lower
October 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7805348 for the full story. Read More
from StreetInsider.com News Articles
Pre-Open Movers 10/19: (RVBD) (CALL) (SNDK) Higher; (CBLI) (CMG) (ATHN) Lower (more...)
October 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7804864 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs (CBLI) Prices $15 Million Common Stock Offering
October 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7804799 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Prices $15 Million Public Offering of Common Stock and Warrants
October 19, 2012
from GlobeNewswire News Releases
Cleveland BioLabs Announces Proposed Public Offering of Common Stock and Warrants
October 18, 2012
from GlobeNewswire News Releases
Cleveland BioLabs Submits Proposal to BARDA for Development Funding for Entolimod(TM) (CBLB502)
October 18, 2012
from GlobeNewswire News Releases
Cleveland Biolabs (CBLI) JV Initiates CBL0137 Phase 1
October 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7783681 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs and Incuron Announce Start of Phase 1 Trial for CBL0137
October 10, 2012
from GlobeNewswire News Releases
Feds re-up BioLabs funding for radiation drug
October 04, 2012
Cleveland BioLabs Inc. received an increase in funding from a federal contract supporting its radiation treatment drug. The company will receive another $770,442 from the U.S. Department of Defense... Read More
from National Business News - Local Business News | bizjournals
Department of Defense Defense Threat Reduction Agency Increases Development Contract With Cleveland BioLabs for Entolimod(TM) (CBLB502)
October 04, 2012
from GlobeNewswire News Releases
FDA OKs BioLabs for cancer drug research
October 02, 2012
Cleveland BioLabs Inc. and its subsidiary Incuron LLC have received orphan drug status for a drug under development to treat cancer. The Buffalo company (NASDAQ: CBLI) received the designation from the... Read More
from National Business News - Local Business News | bizjournals
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here